| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.0057 | 1 |